Dr. Walter Peschel of Missoula has been hard at work configuring a new treatment for COVID-19. He says the treatment is cost-effective and easily manufactured, consisting of four readily available FDA-approved anti-inflammatory drugs.
Together, Peschel says these drugs lower the immune response to illnesses like the coronavirus.
“Developed over 30 years, this four-drug anti-inflammatory protocol -- some people call it the Peschel Protocol -- is safe, inexpensive, durable and highly efficacious when compared to other anti-inflammatories,” said Peschel.
In an off-label trial of volunteer patients, Peschel used this cocktail on six people who tested positive for COVID-19 and measured their stats. According to Peschel, none of the patients had to be admitted to the hospital, they all experienced few to no symptoms, and their immune response and oxygen levels stayed at normal levels.
“Let's give the high-risk patients the Peschel Protocol. They get their symptoms, get their diagnosis, and we start treatment as soon as possible,” said Peschel. “Treat them daily with these four drugs for the course of the illness, we measure the CRP, the oxygen sats, we graph it out, and we have almost normalized the most aggressive immune response to near normal. We’ve eliminated all the end point of hospitalization and death in both high-risk and low-risk patients, 100%,” said Peschel.
Peschel has been working to obtain FDA approval; however, he says the process is difficult. He has been gaining more momentum locally, and Missoula Mayor John Engen voiced his support for the treatment.
“FDA is a hard bureaucracy to crack. As Dr. Peschel will tell you, there's not much money to be made here, and that's part of the problem,” said Engen.
Engen plans to help back Peschel in any way he can.
“I've long been in support of Walt getting a chance to test this in a really meaningful way. What I know is that the folks who have volunteered to use the Peschel Protocol have seen chronic disease arrested,” said Engen.
One of Peschel’s higher risk patients, Phil Currie, was put on the Peschel Protocol when he first tested positive for the virus. He says he had few symptoms and fully recovered.
“I had a little bit of a stuffy nose, but that's all, and for somebody who's at high risk, I'm 80 years old,” said Currie.
Right now, Peschel wants to expand his protocol to more patients and measure those results.
“I would recommend that we find out if the protocol reduces these endpoints adequately. I would then manufacture as much of this medicine as I could and use it to control the present pandemic” said Peschel.
Those interested in learning more about the protocol are encouraged to call Peschel at his number directly: 406-880-3343